Resultats de la cerca - Gibson, Michael K

Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma per Das, Satya, Gibson, Michael K

Obtenir text complet Obtenir text complet Obtenir text complet

A Rare Case of Malignant Glomus Tumor of the Esophagus per Bali, Gurvinder Singh, Hartman, Douglas J., Haight, Joel B., Gibson, Michael K.

Obtenir text complet Obtenir text complet Obtenir text complet

Inherited disorders of GABA metabolism per Pearl, Phillip L, Hartka, Thomas R, Cabalza, Jessica L, Taylor, Jacob, Gibson, Michael K

Obtenir text complet Obtenir text complet Obtenir text complet

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcino... per Zahoor, Haris, Luketich, James D., Levy, Ryan M., Awais, Omar, Winger, Daniel G., Gibson, Michael K., Nason, Katie S.

Obtenir text complet Obtenir text complet Obtenir text complet

MUC2 Expression is an Adverse Prognostic Factor in Superficial Gastroesophageal Adenocarcinomas per Davison, Jon M., Ellis, Shane T., Foxwell, Tyler J., Luketich, James D., Gibson, Michael K., Kuan, Shih-Fan, Nason, Katie S.

Obtenir text complet Obtenir text complet Obtenir text complet

A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer per Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.

Obtenir text complet Obtenir text complet

Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer per LaPelusa, Michael, Shen, Chan, Gillaspie, Erin A., Cann, Christopher, Lambright, Eric, Chakravarthy, A. Bapsi, Gibson, Michael K., Eng, Cathy

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma per Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.

Obtenir text complet Obtenir text complet Obtenir text complet

A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes per Davison, Jon M., Landau, Michael S., Luketich, James D., McGrath, Kevin M., Foxwell, Tyler J., Landsittel, Douglas P., Gibson, Michael K., Nason, Katie S.

Obtenir text complet Obtenir text complet Obtenir text complet

Outcomes with FOLFIRINOX for Borderline Resectable and Locally Unresectable Pancreatic Cancer per Boone, Brian A., Steve, Jennifer, Krasinskas, Alyssa M., Zureikat, Amer H., Lembersky, Barry C., Gibson, Michael K., Stoller, Ronald, Zeh, Herbert J., Bahary, Nathan

Obtenir text complet Obtenir text complet Obtenir text complet

The revised AJCC Staging System (7th Edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma per Zahoor, Haris, Luketich, James D., Weksler, Benny, Winger, Daniel G., Christie, Neil A., Levy, Ryan M., Gibson, Michael K., Davison, Jon M., Nason, Katie S.

Obtenir text complet Obtenir text complet Obtenir text complet

Esophagectomy for T1 esophageal cancer: Outcomes in 100 patients and Implications for Endoscopic therapy per Pennathur, Arjun, Farkas, Andrew, Krasinskas, Alyssa M, Ferson, Peter F, Gooding, William E, Gibson, Michael K, Schuchert, Matthew J, Landreneau, Rodney J, Luketich, James D

Obtenir text complet Obtenir text complet Obtenir text complet

Cardiovascular Risk and Prevention in Head and Neck Cancer Patients Treated with Radiotherapy per Okoye, Christian C, Bucher, Jessica, Tatsuoka, Curtis, Parikh, Sahil A, Oliveira, Guilherme H, Gibson, Michael K, Machtay, Mitchell, Yao, Min, Zender, Chad A, Dorth, Jennifer A

Obtenir text complet Obtenir text complet Obtenir text complet

The Impact of Tumor Volume and Radiotherapy Dose on Outcome in Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck Treated With Stereotactic Body Radiation... per Rwigema, Jean-Claude M., Heron, Dwight E., Ferris, Robert L., Andrade, Regiane S., Gibson, Michael K., Yang, Yong, Ozhasoglu, Cihat, Argiris, Athanassios E., Grandis, Jennifer R., Burton, Steven A.

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5‐Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adeno... per Gibson, Michael K., Catalano, Paul, Kleinberg, Lawrence R., Staley, Charles A., Montgomery, Elizabeth A., Jimeno, Antonio, Song, Wei (Frank), Mulcahy, Mary F., Leichman, Lawrence P., Benson, Al B.

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma per Geiger, Jessica L., Bauman, Julie E., Gibson, Michael K., Gooding, William E., Varadarajan, Prakash, Kotsakis, Athanasios, Martin, Daniel, Gutkind, Jorge Silvio, Hedberg, Matthew L., Grandis, Jennifer R., Argiris, Athanassios

Obtenir text complet Obtenir text complet Obtenir text complet

Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium per Malhotra, Usha, Zaidi, Ali H., Kosovec, Juliann E., Kasi, Pashtoon M., Komatsu, Yoshihiro, Rotoloni, Christina L., Davison, Jon M., R, Clint, Irvin, Hoppo, Toshitaka, Nason, Katie S., Kelly, Lori A., Gibson, Michael K., Jobe, Blair A.

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer per Bauman, Julie E., Julian, Ricklie, Saba, Nabil F., Wise-Draper, Trisha M., Adkins, Douglas R., O’Brien, Paul, Fidler, Mary Jo, Gibson, Michael K., Duvvuri, Umamaheswar, Heath-Chiozzi, Margo, Alvarado, Diego, Gedrich, Richard, Golden, Philip, Cohen, Roger B.

Obtenir text complet Obtenir text complet Obtenir text complet

Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Nec... per Argiris, Athanassios, Heron, Dwight E., Smith, Ryan P., Kim, Seungwon, Gibson, Michael K., Lai, Stephen Y., Branstetter, Barton F., Posluszny, Donna M., Wang, Lin, Seethala, Raja R., Dacic, Sanja, Gooding, William, Grandis, Jennifer R., Johnson, Jonas T., Ferris, Robert L.

Obtenir text complet Obtenir text complet Obtenir text complet

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study per Bauml, Joshua, Seiwert, Tanguy Y., Pfister, David G., Worden, Francis, Liu, Stephen V., Gilbert, Jill, Saba, Nabil F., Weiss, Jared, Wirth, Lori, Sukari, Ammar, Kang, Hyunseok, Gibson, Michael K., Massarelli, Erminia, Powell, Steven, Meister, Amy, Shu, Xinxin, Cheng, Jonathan D., Haddad, Robert

Obtenir text complet Obtenir text complet Obtenir text complet